speb/financial-data huggingface dataset:
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 305120000.00
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 798640000.00
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 141120000.00
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 78810000.00
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1626580000.00
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
MEDIASSIST.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1083090000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 2325450000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 511060000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3382010000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 337150000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 70318584.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.13
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 614910000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 353250000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 557790000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2323060000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 353250000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5792880000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1054500000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 6150100000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 175210000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1463620000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1638830000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 6282470000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 253120000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 209320000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 209320000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 70946429.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.12
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 79460000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — EBIT: 210610000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — EBITDA: 419930000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 3507840000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 5823170000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 968020000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1270950000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 75930000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 75930000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8226430000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 337150000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 439700000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 969930000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1409630000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 328720000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 118620000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -1210000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1875760000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Income: 79460000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 79460000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 80670000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 79460000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 79460000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 80670000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -75930000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -75930000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 968020000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -30290000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 0.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 86200000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 419930000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 79460000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Operating Income: 187860000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2325450000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 70649862.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 445030000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 113890000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 5439630000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2315330000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 32640000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 22750000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 873770000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 968020000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1765270000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Payables: 515700000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 134680000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1054500000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 209320000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 70649862.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5792880000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -30290000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 54010000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 14200030000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6762810000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 3048460000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5911500000.00
MEDIASSIST.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 2137590000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 8288530000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 8049930000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2006060000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 4640000.00
MEDIASSIST.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -132370000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1128160000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2396780000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 81764706.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.51
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1033740000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 211300000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 211300000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 81764706.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.51
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 41700000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — EBIT: 168570000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — EBITDA: 379870000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1363040000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 83890000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 83890000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 340000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Income: 41700000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 41700000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 41360000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 41700000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 41700000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 41360000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -83890000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -83890000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 521820000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 141065000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Operating Income: 234880000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2396780000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 75640000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 916860000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 84680000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1033740000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 211300000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -141950000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -42585000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 43320000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2161900000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -141950000.00
MEDIASSIST.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -141950000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4132130000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1092940000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9047670000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2419860000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 456010000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 456010000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2866820000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2866820000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 330190000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 330190000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 72396211.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 72911323.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Basic EPS: 12.14
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 7.33
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 830140000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -559220000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 543980000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 543980000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 373050000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 373050000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 546320000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 546320000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2548870000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2548870000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 361650000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -322810000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Change In Payable: -114570000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -296110000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -273010000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -297180000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Common Stock: 373050000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 373050000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: 0.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 8389030000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 8389030000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 2048780000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 3940720000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1053840000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Current Assets: 5851790000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 5851790000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 168230000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 168230000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 168230000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 168230000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 4376410000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4376410000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 230500000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 230500000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Depreciation: 771250000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 771250000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 771250000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 209510000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 771250000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 209510000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 72396211.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 72911323.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Diluted EPS: 12.14
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 7.33
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 878890000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 534440000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — EBIT: 1017640000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — EBIT: 285540000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — EBITDA: 1788890000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — EBITDA: 495050000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 13360000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — End Cash Position: 546320000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 118450000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 621490000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -66780000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Goodwill: 3514400000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 3514400000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 5650020000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 5650020000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 937080000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 937080000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Gross Profit: 5106950000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1366020000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Interest Expense: 214120000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 6500000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 214120000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6500000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -146220000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 45940000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 8389030000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8389030000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1596340000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 330190000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 330190000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 2048780000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 375750000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 375750000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 0.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 0.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 375750000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 375750000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 372180000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 372180000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 134970000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 134970000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Minority Interests: -14220000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -10330000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -4018500000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 2048780000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 22640000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Income: 878890000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Income: 534440000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 878890000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 534440000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 893110000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 544770000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Income Discontinuous Operations: 0.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 0.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 878890000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 534440000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 878890000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 534440000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 803520000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 893110000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 544770000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Interest Income: -214120000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -6500000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 2935440000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -1550700000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -214120000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -6500000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Net PPE: 937080000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 937080000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -559220000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -1550700000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 2739010000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2739010000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 269800000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 269800000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1930840000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 495050000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Normalized Income: 964060000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 534440000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1180710000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Operating Income: 974820000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Operating Income: 273080000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Operating Revenue: 9047670000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2419860000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 74609427.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 74609427.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 436100000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 436100000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 98630000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 98630000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 8015980000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 8015980000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 2135620000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2135620000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 130290000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 12110000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 12110000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 184770000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 12460000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 3360880000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 883430000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Other Properties: 937080000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 937080000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 2002550000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2002550000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Payables: 482110000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Payables: 482110000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Pretax Income: 803520000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 279040000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 24190000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -4018500000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -21750000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -559220000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 3940720000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1053840000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 771250000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 209510000.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 2957190000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Share Issued: 74609427.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 74609427.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Special Income Charges: -141950000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 32260000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 8389030000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 8389030000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 2739010000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2739010000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -56780000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Tax Provision: -89590000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -265730000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
MEDIASSIST.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -264120000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Total Assets: 13724620000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 13724620000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 8389030000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8389030000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Total Debt: 543980000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 543980000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 8524000000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 8524000000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Total Expenses: 8072850000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 2146780000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 5200620000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 5200620000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 7872830000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7872830000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 824210000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 824210000.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 26100000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 26100000.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -141950000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
MEDIASSIST.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -141950000.00
MEDIASSIST.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDIASSIST.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1475380000.00
MEDIASSIST.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1475380000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — +Operating Expense: 289885000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — +Total Revenue: 1154453000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 433000000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 632235000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -312185000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 677045000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Amortization: 993000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 993000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 12216600.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Basic EPS: 12.19
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 38906000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 370279000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -86082000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 122166000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 38248000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 38248000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -12217000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 29890000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 8358000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -218059000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: 22780000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 1249000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Change In Payable: 110886000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -56902000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -178205000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -658000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Common Stock: 122166000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 1464697000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 0.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 674574000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Current Assets: 1230377000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Current Debt: 207223000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 207223000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 42638000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 726908000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 8232000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Deferred Tax: 31971000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Depreciation: 56721000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 57714000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 57714000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 56721000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 12216600.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Diluted EPS: 12.19
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 148977000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 793000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — EBIT: 194954000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — EBITDA: 252668000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — End Cash Position: 38248000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 42979000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 52161000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -44991000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -12000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 44826000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 3599000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 1233357000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Gross Profit: 479879000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Interest Expense: 14006000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 14006000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Interest Income: 1354000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 1354000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -14006000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 1354000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Inventory: 270097000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 1722656000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -84728000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 0.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 83464000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 9424000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 50736000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 50736000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -13310000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 14594000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 695000000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Minority Interests: 0.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Net Debt: 219711000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Net Income: 148977000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 148977000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 148977000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 148977000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 148977000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 148971000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 148977000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Net Interest Income: -18057000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 0.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 70154000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -13310000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -18057000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -952000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Net PPE: 921172000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -86082000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 83464000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 1461098000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 4964000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 14594000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 8652000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 259423000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Normalized Income: 154538485.26
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 41091000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Operating Income: 189994000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Operating Revenue: 1154453000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 12216600.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 237162000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 20349000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 1342532000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 3599000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 88012000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 12652000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 88171000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 1000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 1276000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 4645000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Payable: 14674000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Properties: 158654000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 22370000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Other Special Charges: -60000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Payables: 448467000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8231000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 81573000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Pretax Income: 180948000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: 0.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -86082000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 118347000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 674574000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 57714000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 2527000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 2527000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -13310000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 3065000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 687824000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 32377000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 77203000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Share Issued: 12216600.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 83464000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Special Income Charges: -6772000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 1464697000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 1461098000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -1193514.74
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Tax Provision: 31971000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.18
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 182789000.00
MEDICAMEQ.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -32000000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Total Assets: 2256935000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 1515433000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Total Debt: 257959000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 1464697000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Total Expenses: 964459000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 792238000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 1026558000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 65330000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 5405000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 42638000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -6755000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -6755000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Work In Process: 11577000.00
MEDICAMEQ.NS balance_sheet (annual, 2022-03-31) — Working Capital: 503469000.00
MEDICAMEQ.NS income_statement (annual, 2022-03-31) — Write Off: 6832000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — +Operating Expense: 359864000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — +Total Revenue: 1408674000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 431696000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 652581000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -370969000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 978730000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Amortization: 1103000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 1103000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 12651100.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Basic EPS: 11.73
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 38248000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 371879000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -66011000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 126511000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 207789000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 207789000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -12651000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 181859000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 25930000.00